Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CytoViva
AddedFeb 15, 2024
UpdatedJun 18, 2026
CytoViva

CytoViva

CytoViva: A leading scientific imaging and instrumentation firm since 2005.

HQ
Auburn, AL, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Founded in 2005, CytoViva is a pioneering scientific imaging and instrumentation company dedicated to advancing research capabilities in various scientific fields. The company's core mission is to provide cutting-edge imaging technology that enhances the visualization of nanoscale materials and biological samples. CytoViva offers advanced hyperspectral imaging systems and related products, which are widely used in research laboratories across the globe. Their technology aims to support breakthroughs in nanotechnology, life sciences, and material sciences.

CytoViva's innovative solutions have been adopted by hundreds of research institutions, demonstrating significant impact in scientific discovery and innovation. The company has collaborated with leading researchers and institutions, contributing to numerous peer-reviewed publications and advancements in scientific knowledge. Notable investors and affiliations include partnerships with academic and governmental research bodies. CytoViva's commitment to enhancing scientific imaging has solidified its reputation as a key player in the scientific instrumentation market.

CytoViva - Similar Companies

Cytek Biosciences logo

Cytek Biosciences

cytekbio.com

Vitra Bioscience logo

Vitra Bioscience

Aurora Spectral Technologies logo

Aurora Spectral Technologies

CytoVeris logo

CytoVeris

cytoveris.com

Vivita Technologies logo

Vivita Technologies

CytoMag logo

CytoMag

CytoTronics logo

CytoTronics

cytotronics.com

Thermo Fisher th logo

Thermo Fisher th

thermofisher.com

CytoRecovery logo

CytoRecovery

cytorecovery.com

Cell Microsystems logo

Cell Microsystems

Vivebio logo

Vivebio

InVivo Biosystems logo

InVivo Biosystems

Thrive Bioscience logo

Thrive Bioscience

thrivebio.com

NanoCytomics logo

NanoCytomics

nano-cytomics.com

CyOmics logo

CyOmics

CytoViva - Quick Facts

Who are CytoViva's competitors?

Companies similar to CytoViva include Cytek Biosciences, Vitra Bioscience, Aurora Spectral Technologies and CytoVeris.

When was CytoViva founded?

CytoViva was founded in 2005.

Where is CytoViva's headquarters located?

CytoViva's headquarters is located in Auburn, AL, US.

When was CytoViva's last funding round?

CytoViva's most recent funding round was for $685k (USD) in April 2009.

How much has CytoViva raised to-date?

As of Apr 29, 2009, CytoViva has raised a total of $685k (USD).

How many employees does CytoViva have?

CytoViva has 8 employees as of Feb 5, 2024.

CytoViva - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Education
  • Enterprise
Main Product
  • Imaging
  • Instrumentation
Tags
  • Biotech
  • Data